Severe Liver Injury Associated With High-Dose Atorvastatin Therapy

Area of Science:

• Hepatology
• Clinical Pharmacology

Background:

• Statins are widely prescribed for cholesterol management and cardiovascular disease prevention.
• While generally safe, statins can rarely cause liver injury, ranging from mild transaminase elevations to severe hepatocellular damage.

Observation:

• A 71-year-old male patient developed severe, asymptomatic liver injury in a hepatocellular pattern.
• This occurred within three months of switching from simvastatin to high-intensity atorvastatin therapy.

Findings:

• Atorvastatin was identified as the likely cause of the severe liver injury.
• Hepatitis resolved rapidly after discontinuing atorvastatin.
• Liver function normalized and did not relapse upon re-initiation of simvastatin therapy.

Implications:

• This case underscores the potential for atorvastatin to cause significant, asymptomatic liver injury.
• Clinicians should consider monitoring liver function in patients on high-intensity atorvastatin, especially after medication changes.
• Individual patient responses to statins can vary, necessitating careful drug selection and monitoring for adverse effects.